New Hampshire’s overdose deaths declined significantly in 2024, part of a national trend, yet fentanyl remains prevalent in the drug supply. Despite progress, the state’s drug landscape is complex, with heightened risks from polydrug use involving stimulants and xylazine. Ongoing harm-reduction efforts and treatment advancements are crucial to maintain gains.

